Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 757 to 765 of 765 entries
Sorted by: Best Match Show Resources per page
ST-segment elevation in patients presenting with COVID-19: case series.

European heart journal. Case reports

Saririan M, Armstrong R, George JC, Olechowski B, O'Connor S, Byrd JB, Chapman AR.
PMID: 33644657
Eur Heart J Case Rep. 2021 Feb 08;5(2):ytaa553. doi: 10.1093/ehjcr/ytaa553. eCollection 2021 Feb.

BACKGROUND : The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the now pandemic disease, coronavirus disease (COVID-19). A number of reports have emerged suggesting these patients may present with signs and symptoms consistent with...

Cite
Saririan M, Armstrong R, George JC, et al. ST-segment elevation in patients presenting with COVID-19: case series. Eur Heart J Case Rep. 2021;5(2):ytaa553doi: 10.1093/ehjcr/ytaa553.
Saririan, M., Armstrong, R., George, J. C., Olechowski, B., O'Connor, S., Byrd, J. B., & Chapman, A. R. (2021). ST-segment elevation in patients presenting with COVID-19: case series. European heart journal. Case reports, 5(2), ytaa553. https://doi.org/10.1093/ehjcr/ytaa553
Saririan, Mehrdad, et al. "ST-segment elevation in patients presenting with COVID-19: case series." European heart journal. Case reports vol. 5,2 (2021): ytaa553. doi: https://doi.org/10.1093/ehjcr/ytaa553
Saririan M, Armstrong R, George JC, Olechowski B, O'Connor S, Byrd JB, Chapman AR. ST-segment elevation in patients presenting with COVID-19: case series. Eur Heart J Case Rep. 2021 Feb 08;5(2):ytaa553. doi: 10.1093/ehjcr/ytaa553. eCollection 2021 Feb. PMID: 33644657; PMCID: PMC7898565.
Copy Download .nbib Format: NLM
Does reading a book in bed make a difference to sleep in comparison to not reading a book in bed? The People's Trial-an online, pragmatic, randomised trial.

Trials

Finucane E, O'Brien A, Treweek S, Newell J, Das K, Chapman S, Wicks P, Galvin S, Healy P, Biesty L, Gillies K, Noel-Storr A, Gardner H, O'Reilly MF, Devane D.
PMID: 34996514
Trials. 2021 Dec 04;22(1):873. doi: 10.1186/s13063-021-05831-3.

BACKGROUND: The best way of comparing healthcare treatments is through a randomised trial. In a randomised trial, we compare something (a treatment or intervention) to something else, often another treatment. Who gets what is decided at random, meaning everyone...

Cite
Finucane E, O'Brien A, Treweek S, et al. Does reading a book in bed make a difference to sleep in comparison to not reading a book in bed? The People's Trial-an online, pragmatic, randomised trial. Trials. 2021;22(1):873doi: 10.1186/s13063-021-05831-3.
Finucane, E., O'Brien, A., Treweek, S., Newell, J., Das, K., Chapman, S., Wicks, P., Galvin, S., Healy, P., Biesty, L., Gillies, K., Noel-Storr, A., Gardner, H., O'Reilly, M. F., & Devane, D. (2021). Does reading a book in bed make a difference to sleep in comparison to not reading a book in bed? The People's Trial-an online, pragmatic, randomised trial. Trials, 22(1), 873. https://doi.org/10.1186/s13063-021-05831-3
Finucane, Elaine, et al. "Does reading a book in bed make a difference to sleep in comparison to not reading a book in bed? The People's Trial-an online, pragmatic, randomised trial." Trials vol. 22,1 (2021): 873. doi: https://doi.org/10.1186/s13063-021-05831-3
Finucane E, O'Brien A, Treweek S, Newell J, Das K, Chapman S, Wicks P, Galvin S, Healy P, Biesty L, Gillies K, Noel-Storr A, Gardner H, O'Reilly MF, Devane D. Does reading a book in bed make a difference to sleep in comparison to not reading a book in bed? The People's Trial-an online, pragmatic, randomised trial. Trials. 2021 Dec 04;22(1):873. doi: 10.1186/s13063-021-05831-3. PMID: 34996514.
Copy Download .nbib Format: NLM
Translational Aspects of the Multidisciplinary Study of Metacognition.

Translational issues in psychological science

Chapman S, Colvin LE, Cosentino S.
PMID: 33728364
Transl Issues Psychol Sci. 2020 Mar;6(1):26-31. doi: 10.1037/tps0000224.

Metacognition, self-awareness, self-knowledge, and insight each refer to the process by which individuals reflect upon and appraise their own abilities. Self-awareness is a complex, dynamic, and multifactorial construct that spans various domains such as motor, sensory, functional and cognitive...

Cite
Chapman S, Colvin LE, Cosentino S. Translational Aspects of the Multidisciplinary Study of Metacognition. Transl Issues Psychol Sci. 2020;6(1):26-31doi: 10.1037/tps0000224.
Chapman, S., Colvin, L. E., & Cosentino, S. (2020). Translational Aspects of the Multidisciplinary Study of Metacognition. Translational issues in psychological science, 6(1), 26-31. https://doi.org/10.1037/tps0000224
Chapman, Silvia, et al. "Translational Aspects of the Multidisciplinary Study of Metacognition." Translational issues in psychological science vol. 6,1 (2020): 26-31. doi: https://doi.org/10.1037/tps0000224
Chapman S, Colvin LE, Cosentino S. Translational Aspects of the Multidisciplinary Study of Metacognition. Transl Issues Psychol Sci. 2020 Mar;6(1):26-31. doi: 10.1037/tps0000224. PMID: 33728364; PMCID: PMC7959162.
Copy Download .nbib Format: NLM
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer.

Gut

Chen H, Zheng X, Zong X, Li Z, Li N, Hur J, Fritz CD, Chapman W, Nickel KB, Tipping A, Colditz GA, Giovannucci EL, Olsen MA, Fields RC, Cao Y.
PMID: 33037055
Gut. 2021 Jun;70(6):1147-1154. doi: 10.1136/gutjnl-2020-321661. Epub 2020 Oct 09.

OBJECTIVE: Factors that lead to metabolic dysregulation are associated with increased risk of early-onset colorectal cancer (CRC diagnosed under age 50). However, the association between metabolic syndrome (MetS) and early-onset CRC remains unexamined.DESIGN: We conducted a nested case-control study...

Cite
Chen H, Zheng X, Zong X, et al. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut. 2020;70(6):1147-1154doi: 10.1136/gutjnl-2020-321661.
Chen, H., Zheng, X., Zong, X., Li, Z., Li, N., Hur, J., Fritz, C. D., Chapman, W., Nickel, K. B., Tipping, A., Colditz, G. A., Giovannucci, E. L., Olsen, M. A., Fields, R. C., & Cao, Y. (2021). Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut, 70(6), 1147-1154. https://doi.org/10.1136/gutjnl-2020-321661
Chen, Hanyu, et al. "Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer." Gut vol. 70,6 (2021): 1147-1154. doi: https://doi.org/10.1136/gutjnl-2020-321661
Chen H, Zheng X, Zong X, Li Z, Li N, Hur J, Fritz CD, Chapman W, Nickel KB, Tipping A, Colditz GA, Giovannucci EL, Olsen MA, Fields RC, Cao Y. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut. 2021 Jun;70(6):1147-1154. doi: 10.1136/gutjnl-2020-321661. Epub 2020 Oct 09. PMID: 33037055; PMCID: PMC8032822.
Copy Download .nbib Format: NLM
AFYA BORA CONSORTIUM FELLOWSHIP: a journey of success in Global Health Leadership Training.

African health sciences

Gachuno O, Odero T, Seloilwe E, Urassa D, Tarimo E, Nakanjako D, Sewankambo N, Atanga NS, Halle-Ekane EG, Manabe Y, Hosey KN, Chapman SA, Wiebe DJ, Voss J, O'Malley G, Mashalla Y, Ndegwa M, Omogi J, Farquhar C, Wasserheit JN.
PMID: 34447427
Afr Health Sci. 2021 May;21:i-ii. doi: 10.4314/ahs.v21i1.1S.

No abstract available.

Cite
Gachuno O, Odero T, Seloilwe E, et al. AFYA BORA CONSORTIUM FELLOWSHIP: a journey of success in Global Health Leadership Training. Afr Health Sci. 2021;21:i-iidoi: 10.4314/ahs.v21i1.1S.
Gachuno, O., Odero, T., Seloilwe, E., Urassa, D., Tarimo, E., Nakanjako, D., Sewankambo, N., Atanga, N. S., Halle-Ekane, E. G., Manabe, Y., Hosey, K. N., Chapman, S. A., Wiebe, D. J., Voss, J., O'Malley, G., Mashalla, Y., Ndegwa, M., Omogi, J., Farquhar, C., & Wasserheit, J. N. (2021). AFYA BORA CONSORTIUM FELLOWSHIP: a journey of success in Global Health Leadership Training. African health sciences, 21i-ii. https://doi.org/10.4314/ahs.v21i1.1S
Gachuno, Onesmus, et al. "AFYA BORA CONSORTIUM FELLOWSHIP: a journey of success in Global Health Leadership Training." African health sciences vol. 21 (2021): i-ii. doi: https://doi.org/10.4314/ahs.v21i1.1S
Gachuno O, Odero T, Seloilwe E, Urassa D, Tarimo E, Nakanjako D, Sewankambo N, Atanga NS, Halle-Ekane EG, Manabe Y, Hosey KN, Chapman SA, Wiebe DJ, Voss J, O'Malley G, Mashalla Y, Ndegwa M, Omogi J, Farquhar C, Wasserheit JN. AFYA BORA CONSORTIUM FELLOWSHIP: a journey of success in Global Health Leadership Training. Afr Health Sci. 2021 May;21:i-ii. doi: 10.4314/ahs.v21i1.1S. PMID: 34447427; PMCID: PMC8367302.
Copy Download .nbib Format: NLM
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.

Kidney international reports

El Ters M, Lu P, Mahnken JD, Stubbs JR, Zhang S, Wallace DP, Grantham JJ, Chapman AB, Torres VE, Harris PC, Bae KT, Landsittel DP, Rahbari-Oskoui FF, Mrug M, Bennett WM, Yu ASL.
PMID: 33912745
Kidney Int Rep. 2021 Jan 16;6(4):953-961. doi: 10.1016/j.ekir.2021.01.004. eCollection 2021 Apr.

INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst growth and a loss of functioning renal mass, but a decline in glomerular filtration rate (GFR) and onset of end-stage renal disease (ESRD) occur late in the...

Cite
El Ters M, Lu P, Mahnken JD, et al. Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep. 2021;6(4):953-961doi: 10.1016/j.ekir.2021.01.004.
El Ters, M., Lu, P., Mahnken, J. D., Stubbs, J. R., Zhang, S., Wallace, D. P., Grantham, J. J., Chapman, A. B., Torres, V. E., Harris, P. C., Bae, K. T., Landsittel, D. P., Rahbari-Oskoui, F. F., Mrug, M., Bennett, W. M., & Yu, A. S. L. (2021). Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease. Kidney international reports, 6(4), 953-961. https://doi.org/10.1016/j.ekir.2021.01.004
El Ters, Mireille, et al. "Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease." Kidney international reports vol. 6,4 (2021): 953-961. doi: https://doi.org/10.1016/j.ekir.2021.01.004
El Ters M, Lu P, Mahnken JD, Stubbs JR, Zhang S, Wallace DP, Grantham JJ, Chapman AB, Torres VE, Harris PC, Bae KT, Landsittel DP, Rahbari-Oskoui FF, Mrug M, Bennett WM, Yu ASL. Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep. 2021 Jan 16;6(4):953-961. doi: 10.1016/j.ekir.2021.01.004. eCollection 2021 Apr. PMID: 33912745; PMCID: PMC8071629.
Copy Download .nbib Format: NLM
Increased admissions to paediatric wards with a primary mental health diagnosis: results of a survey of a network of eating disorder paediatricians in England.

Archives of disease in childhood

Hudson LD, Chapman S, Street KN, Nicholls D, Roland D, Dubicka B, Gibson F, Mathews G, Viner RM.
PMID: 34521633
Arch Dis Child. 2021 Sep 14; doi: 10.1136/archdischild-2021-322700. Epub 2021 Sep 14.

No abstract available.

Cite
Hudson LD, Chapman S, Street KN, et al. Increased admissions to paediatric wards with a primary mental health diagnosis: results of a survey of a network of eating disorder paediatricians in England. Arch Dis Child. 2021;doi: 10.1136/archdischild-2021-322700.
Hudson, L. D., Chapman, S., Street, K. N., Nicholls, D., Roland, D., Dubicka, B., Gibson, F., Mathews, G., & Viner, R. M. (2021). Increased admissions to paediatric wards with a primary mental health diagnosis: results of a survey of a network of eating disorder paediatricians in England. Archives of disease in childhood, . https://doi.org/10.1136/archdischild-2021-322700
Hudson, Lee D, et al. "Increased admissions to paediatric wards with a primary mental health diagnosis: results of a survey of a network of eating disorder paediatricians in England." Archives of disease in childhood vol. (2021). doi: https://doi.org/10.1136/archdischild-2021-322700
Hudson LD, Chapman S, Street KN, Nicholls D, Roland D, Dubicka B, Gibson F, Mathews G, Viner RM. Increased admissions to paediatric wards with a primary mental health diagnosis: results of a survey of a network of eating disorder paediatricians in England. Arch Dis Child. 2021 Sep 14; doi: 10.1136/archdischild-2021-322700. Epub 2021 Sep 14. PMID: 34521633.
Copy Download .nbib Format: NLM
Rib Fracture Mortality: Are There Clues in the Core?.

The Journal of surgical research

Kelly-Schuette KA, Prentice A, Orr A, Levine A, Zarnke A, Pardington E, Pounders S, Lypka M, Krech L, Iskander G, Chapman AJ, Gibson CJ, Steensma E, Durling L.
PMID: 34280662
J Surg Res. 2021 Dec;268:25-32. doi: 10.1016/j.jss.2021.06.020. Epub 2021 Jul 17.

BACKGROUND: Sarcopenia is associated with increased morbidity and mortality in the trauma patient. The primary objective of this study was to determine the relationship of psoas cross sectional area with hospital mortality in patients with rib fractures over the...

Cite
Kelly-Schuette KA, Prentice A, Orr A, et al. Rib Fracture Mortality: Are There Clues in the Core?. J Surg Res. 2021;268:25-32doi: 10.1016/j.jss.2021.06.020.
Kelly-Schuette, K. A., Prentice, A., Orr, A., Levine, A., Zarnke, A., Pardington, E., Pounders, S., Lypka, M., Krech, L., Iskander, G., Chapman, A. J., Gibson, C. J., Steensma, E., & Durling, L. (2021). Rib Fracture Mortality: Are There Clues in the Core?. The Journal of surgical research, 26825-32. https://doi.org/10.1016/j.jss.2021.06.020
Kelly-Schuette, Kathrine A, et al. "Rib Fracture Mortality: Are There Clues in the Core?." The Journal of surgical research vol. 268 (2021): 25-32. doi: https://doi.org/10.1016/j.jss.2021.06.020
Kelly-Schuette KA, Prentice A, Orr A, Levine A, Zarnke A, Pardington E, Pounders S, Lypka M, Krech L, Iskander G, Chapman AJ, Gibson CJ, Steensma E, Durling L. Rib Fracture Mortality: Are There Clues in the Core?. J Surg Res. 2021 Dec;268:25-32. doi: 10.1016/j.jss.2021.06.020. Epub 2021 Jul 17. PMID: 34280662.
Copy Download .nbib Format: NLM
Female Faculty Members in University Chemistry Departments: Observations and Conclusions Based on Site Visits.

Chapman S, Dixon FF, Foster N, Kuck VJ, McCarthy DA, Tooney NM, Buckner JP, Nolan SA, Marzabadi CH.
UIID-AD: 209
2011;88:716-720. doi: 10.1021/ed100098q.

Oral interviews in focus groups and written surveys were conducted with 877 men and women, including administrators, faculty members, postdoctoral associates, and graduate students, during one-day site visits to chemistry and chemical engineering departments at 28 Ph.D.-granting institutions. This...

Cite
Chapman S, Dixon FF, Foster N, et al. Female Faculty Members in University Chemistry Departments: Observations and Conclusions Based on Site Visits. 2011;88:716-720doi: 10.1021/ed100098q.
Chapman, S., Dixon, F. F., Foster, N., Kuck, V. J., McCarthy, D. A., Tooney, N. M., Buckner, J. P., Nolan, S. A., & Marzabadi, C. H. (2011). Female Faculty Members in University Chemistry Departments: Observations and Conclusions Based on Site Visits. 88716-720. https://doi.org/10.1021/ed100098q
Chapman, S, et al. "Female Faculty Members in University Chemistry Departments: Observations and Conclusions Based on Site Visits." vol. 88 (2011): 716-720. doi: https://doi.org/10.1021/ed100098q
Chapman S, Dixon FF, Foster N, Kuck VJ, McCarthy DA, Tooney NM, Buckner JP, Nolan SA, Marzabadi CH. Female Faculty Members in University Chemistry Departments: Observations and Conclusions Based on Site Visits. 2011;88:716-720. doi: 10.1021/ed100098q. UIID-AD: 209.
Copy Download .nbib Format: NLM
Showing 757 to 765 of 765 entries